Schering Plough Corporation

Schering Plough Corporation is a global pharmaceutical company that provides a wide range of healthcare products and services to the U.S. federal government through its subsidiaries. The company, now part of Merck & Co., specializes in prescription drugs, vaccines, and consumer health products. Schering Plough's primary subsidiaries involved in federal contracting include Merck Sharp & Dohme LLC (doing business as Merck) and Biomark LLC (doing business as Biomark Inc of Idaho). These subsidiaries offer diverse products and services, ranging from pharmaceuticals and vaccines to fish and wildlife tracking technologies, supporting various federal agencies in healthcare, research, and natural resource management initiatives.

Merck Sharp & Dohme LLC has been awarded numerous federal contracts to supply vaccines and pharmaceutical products to agencies such as the Department of Veterans Affairs, Department of Defense, and Centers for Disease Control and Prevention. Notable contract awards include a $3.7 billion agreement with the Department of the Army for the manufacturing and supply of the COVID-19 oral antiviral molnupiravir, as well as multiple delivery orders for various vaccines including MMR, varicella, and hepatitis. The company has also provided vaccines to the Federal Bureau of Investigation and National Guard units. These contracts are typically awarded without set-aside designations, reflecting Merck's status as a large pharmaceutical manufacturer competing in the open market.

Biomark LLC, another subsidiary of Schering Plough Corporation, has received numerous federal contract awards for the provision of fish and wildlife tracking equipment, primarily passive integrated transponder (PIT) tags, readers, and antenna systems. The company has supported natural resource management initiatives for agencies such as the U.S. Fish and Wildlife Service, Bureau of Reclamation, U.S. Geological Survey, and National Oceanic and Atmospheric Administration. Biomark's contracts often involve supplying specialized biologging devices and telemetry equipment for monitoring fish populations, particularly salmon and steelhead in the Pacific Northwest region. These awards are typically made without set-aside designations and are often issued as delivery orders against existing indefinite delivery contracts.

Schering Plough Corporation, through its subsidiaries, holds several significant federal contract IDVs. Merck Sharp & Dohme LLC has been awarded multiple indefinite delivery contracts by the Centers for Disease Control and Prevention for vaccine-related services. These include a $13 million single-award IDV for vaccine storage and rotation services through September 2026, a $94.3 million multiple-award IDV for adult vaccines through June 2023, and a $2.565 billion multiple-award IDV for pediatric vaccines under the Vaccines for Children program. These IDVs allow various federal agencies to place orders for vaccines and related services, providing flexibility in vaccine procurement aligned with public health priorities. Additionally, Merck holds a Federal Supply Schedule contract (FSS-61-IB) for Pharmaceuticals and Drugs, under which numerous delivery orders have been issued by various agencies for vaccine purchases.